Skip to content

Using GLP-1s

Telogen effluvium

Temporary, diffuse hair shedding triggered by a physical stress such as rapid weight loss — the usual explanation for hair loss on a GLP-1, and one that typically reverses on its own.

By the glp1.how editorial teamReviewed

Telogen effluvium is the medical name for a burst of hair shedding that happens when a stress on the body — illness, surgery, childbirth, a crash in calorie intake, or rapid weight loss — pushes an unusually large share of hair follicles from their growing phase into their resting ("telogen") phase at the same time. Those hairs then fall out together roughly two to three months later, which is why the shedding seems to come out of nowhere.

This is the mechanism behind most hair loss on a GLP-1: the medication itself is not thought to attack hair, but the rapid weight loss and reduced protein and micronutrient intake it can cause are classic triggers. Telogen effluvium is diffuse (thinning all over rather than patches or a receding line) and usually self-limiting. Shedding typically slows within about six months once weight stabilizes and nutrition is adequate. See hair loss on a GLP-1: what the evidence actually shows. The American Academy of Dermatology lists losing 20 pounds or more among common triggers and says hair tends to regain its normal fullness within six to nine months (AAD (external link)).

telogen-effluviumhair-lossside-effectsweight-loss

Revision history

Updated 2 times since Sep 2, 2026 · show changes
  1. v3

    Body revised

  2. v2

    Body revised

  3. v1

    Change tracking began

Related guides

  • Hair loss on a GLP-1: what the evidence actually shows · Hair loss is listed as an adverse reaction on the Zepbound label, and recent research shows it's a real, well-documented effect. It is most plausibly tied to rapid weight loss, and the most common type is temporary. What the evidence shows and what can help.
  • Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis · GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.
  • GLP-1 super-responders (and non-responders): why weight loss varies so much · On the same drug at the same dose, one person loses 25% of their body weight and another loses almost nothing. In the tirzepatide trials, half or more of people on the higher doses lost 20% or more, but a large real-world analysis found only about 1 in 8 lost more than 15% in a year, while nearly half lost under 5%. What predicts a strong response (early weight change, drug choice, sex, diabetes, biology), why real-world results trail the trials, and what to do if you're not responding.
  • Loose skin after GLP-1 weight loss: what actually helps and what's hype · Loose or excess skin on the belly, arms, and thighs is a common worry after large GLP-1 weight loss. What the evidence supports (gradual loss, muscle, nutrition, time), which creams and wraps promise more than they deliver, and when surgery is the only real fix.
  • What is suppression, satiation, and satiety on a GLP-1? · GLP-1 medications change appetite in three related but distinct ways: suppression, satiation, and satiety. What each means and what to expect.
  • GLP-1s with insulin or sulfonylureas: understanding hypoglycemia risk · A GLP-1 on its own rarely causes low blood sugar, but pairing it with insulin or a sulfonylurea meaningfully raises the risk. Why, how to recognize hypoglycemia, and what to settle with your prescriber before any dose changes.

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.

Was this helpful?

Improve this page